Aberrant promoter CpG methylation and its translational applications in breast cancer.
Aberrant promoter CpG methylation and its translational applications in breast cancer.
复制标题
异常启动子CpG甲基化及其在乳腺癌中的转化应用
DOI:
10.5732/cjc.011.10344
复制
发表时间:
2013-01
影响因子:
--
通讯作者:
Tao Q
中科院分区:
文献类型:
--
作者:
Xiang TX;Yuan Y;Li LL;Wang ZH;Dan LY;Chen Y;Ren GS;Tao Q
Breast cancer is a complex disease driven by multiple factors including both genetic and epigenetic alterations. Recent studies revealed that abnormal gene expression induced by epigenetic changes, including aberrant promoter methylation and histone modification, plays a critical role in human breast Carcinogenesis. Silencing of tumor suppressor genes (TSGs) by promoter CpG methylation facilitates cells growth and survival advantages and further results in tumor initiation and progression, thus directly contributing to breast tumorigenesis. Usually, aberrant promoter methylation of TSGs, which can be reversed by pharmacological reagents, occurs at the early stage of tumorigenesis and therefore may serve as a potential tumor marker for early diagnosis and therapeutic targeting of breast cancer. In this review, we summarize the epigenetic changes of multiple TSGs involved in breast pathogenesis and their potential clinical applications as tumor markers for early detection and treatment of breast cancer.
登录
查看更多内容
影响因子:
4.7
作者:
Ai, Lingbao;Tao, Qian;Robertson, Keith D.
通讯作者:
Robertson, Keith D.
影响因子:
30.8
作者:
Cameron, EE;Bachman, KE;Baylin, SB
通讯作者:
Baylin, SB
影响因子:
11.5
作者:
Bali, P;Pranpat, M;Bhalla, K
通讯作者:
Bhalla, K
影响因子:
3.7
作者:
Cui Y;Ying Y;van Hasselt A;Ng KM;Yu J;Zhang Q;Jin J;Liu D;Rhim JS;Rha SY;Loyo M;Chan AT;Srivastava G;Tsao GS;Sellar GC;Sung JJ;Sidransky D;Tao Q
通讯作者:
Tao Q
影响因子:
11.5
作者:
Dulaimi, E;Hillinck, J;Cairns, P
通讯作者:
Cairns, P